Literature DB >> 2528652

Dopamine receptor subtypes in renal brush border and basolateral membranes.

C C Felder1, A M McKelvey, M S Gitler, G M Eisner, P A Jose.   

Abstract

Dopamine (DA) modulates renal tubular sodium transport by actions at both brush border (BBM) and basolateral membranes (BLM). DA receptors have been demonstrated in proximal tubule but the subtype of DA receptor in either BBM or BLM has not been determined. DA-1 receptors were quantitated by the specific binding of 125I-SCH 23982, a DA-1 antagonist (defined by 20 microM SCH 23390, a DA-1 antagonist) and DA-2 receptors by the specific binding of 3H-methyl-spiroperidol or 3H-spiroperidol (defined by 30 microM trifluperidol, a predominantly DA-2 antagonist). The specific binding of 125I-SCH 23982 and 3H-methyl-spiroperidol or 3H-spiroperidol were saturable with time and ligand concentration and reversible. Analysis of Rosenthal plots by non-linear regression revealed a high affinity site and a very low affinity site for both BLM and BBM. Maximum receptor density was similar in BBM and BLM. Competition experiments with 125I-SCH 23982 revealed high and low affinity binding sites in both BBM and BLM. The high affinity site was characteristic of a DA-1 receptor. Competition experiments with 3H-spiroperidol were also suggestive of DA-2 receptors. DA-1 but not DA-2 drugs increased adenylate cyclase and phospholipase-C activities in both BBM and BLM. However, their effects were greater in BLM than BBM. We conclude that DA-1 and DA-2 receptors are present in both BBM and BLM in canine kidney. Renal DA-1 receptors are linked to stimulation of both adenylate cyclase and phospholipase-C activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528652     DOI: 10.1038/ki.1989.178

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Luminal vasopressin modulates transport in the rabbit cortical collecting duct.

Authors:  Y Ando; K Tabei; Y Asano
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

2.  Localization of dopamine-1 receptors along the microdissected rat nephron.

Authors:  F Takemoto; T Satoh; H T Cohen; A I Katz
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

3.  Phosphatidylinositol 3-kinase-mediated endocytosis of renal Na+, K+-ATPase alpha subunit in response to dopamine.

Authors:  A V Chibalin; J R Zierath; A I Katz; P O Berggren; A M Bertorello
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

4.  Biochemical, autoradiographic and pharmacological evidence for the involvement of tubular DA-1 receptors in the natriuretic response to dopexamine hydrochloride.

Authors:  S J Vyas; S Apparsundaram; A Ricci; F Amenta; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

5.  The dopamine D(2) receptor is expressed and sensitizes adenylyl cyclase activity in airway smooth muscle.

Authors:  Kentaro Mizuta; Yi Zhang; Dingbang Xu; Eiji Masaki; Reynold A Panettieri; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

6.  Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron.

Authors:  F Takemoto; H T Cohen; T Satoh; A I Katz
Journal:  Pflugers Arch       Date:  1992-07       Impact factor: 3.657

7.  Inhibition of proximal convoluted tubule transport by dopamine.

Authors:  M Baum; R Quigley
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

8.  Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.

Authors:  C Chen; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

Review 9.  Dopamine receptors and hypertension.

Authors:  Anees Ahmad Banday; Mustafa F Lokhandwala
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

10.  Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors.

Authors:  R Perrichot; A Garcia-Ocaña; S Couette; E Comoy; C Amiel; G Friedlander
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.